These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 22591361)

  • 21. Structural and Functional Dysregulation of the Brain Endothelium in HIV Infection and Substance Abuse.
    Annadurai N; Kanmogne GD
    Cells; 2024 Aug; 13(17):. PubMed ID: 39272987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drugs of abuse-induced hyperthermia, blood-brain barrier dysfunction and neurotoxicity: neuroprotective effects of a new antioxidant compound H-290/51.
    Sharma HS; Sjöquist PO; Ali SF
    Curr Pharm Des; 2007; 13(18):1903-23. PubMed ID: 17584116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular basis for interactions of HIV and drugs of abuse.
    Nath A; Hauser KF; Wojna V; Booze RM; Maragos W; Prendergast M; Cass W; Turchan JT
    J Acquir Immune Defic Syndr; 2002 Oct; 31 Suppl 2():S62-9. PubMed ID: 12394784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ethanol pre-exposure suppresses HIV-1 glycoprotein 120-induced neuronal degeneration by abrogating endogenous glutamate/Ca2+-mediated neurotoxicity.
    Belmadani A; Zou JY; Schipma MJ; Neafsey EJ; Collins MA
    Neuroscience; 2001; 104(3):769-81. PubMed ID: 11440808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive deficits associated with combined HIV gp120 expression and chronic methamphetamine exposure in mice.
    Kesby JP; Markou A; Semenova S;
    Eur Neuropsychopharmacol; 2015 Jan; 25(1):141-50. PubMed ID: 25476577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human Immunodeficiency Virus Type 1 and Methamphetamine-Mediated Mitochondrial Damage and Neuronal Degeneration in Human Neurons.
    Teodorof-Diedrich C; Spector SA
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32796068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [HIV-1 neuropathogenesis: therapeutic strategies against neuronal loss induced by gp120/Tat glycoprotein in the central nervous system].
    Merino JJ; Montes ML; Blanco A; Bustos MJ; Oreja-Guevara C; Bayon C; Cuadrado A; Lubrini G; Cambron I; Munoz A; Cebolla S; Gutierrez-Fernandez M; Bernardino JI; Arribas JR; Fiala M
    Rev Neurol; 2011 Jan; 52(2):101-11. PubMed ID: 21271550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protecting neurons from HIV-1 gp120-induced oxidant stress using both localized intracerebral and generalized intraventricular administration of antioxidant enzymes delivered by SV40-derived vectors.
    Louboutin JP; Agrawal L; Reyes BA; Van Bockstaele EJ; Strayer DS
    Gene Ther; 2007 Dec; 14(23):1650-61. PubMed ID: 17914406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of HIV gp120 protein increases sensitivity to the rewarding properties of methamphetamine in mice.
    Kesby JP; Hubbard DT; Markou A; Semenova S
    Addict Biol; 2014 Jul; 19(4):593-605. PubMed ID: 23252824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proceedings of the 2017 ISEV symposium on "HIV, NeuroHIV, drug abuse, & EVs".
    Hu G; Yelamanchili S; Kashanchi F; Haughey N; Bond VC; Witwer KW; Pulliam L; Buch S
    J Neurovirol; 2017 Dec; 23(6):935-940. PubMed ID: 29147885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV and substance abuse: a commentary.
    Shurtleff D; Lawrence D
    Curr HIV Res; 2012 Jul; 10(5):366-8. PubMed ID: 22591360
    [No Abstract]   [Full Text] [Related]  

  • 32. A failure to normalize biochemical and metabolic insults during morphine withdrawal disrupts synaptic repair in mice transgenic for HIV-gp120.
    Bandaru VV; Patel N; Ewaleifoh O; Haughey NJ
    J Neuroimmune Pharmacol; 2011 Dec; 6(4):640-9. PubMed ID: 21748284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opiate drug use and the pathophysiology of neuroAIDS.
    Hauser KF; Fitting S; Dever SM; Podhaizer EM; Knapp PE
    Curr HIV Res; 2012 Jul; 10(5):435-52. PubMed ID: 22591368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice.
    Toggas SM; Masliah E; Rockenstein EM; Rall GF; Abraham CR; Mucke L
    Nature; 1994 Jan; 367(6459):188-93. PubMed ID: 8114918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cocaine and human immunodeficiency virus type 1 gp120 mediate neurotoxicity through overlapping signaling pathways.
    Yao H; Allen JE; Zhu X; Callen S; Buch S
    J Neurovirol; 2009 Apr; 15(2):164-75. PubMed ID: 19319745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A rat model of human immunodeficiency virus 1 encephalopathy using envelope glycoprotein gp120 expression delivered by SV40 vectors.
    Louboutin JP; Agrawal L; Reyes BA; Van Bockstaele EJ; Strayer DS
    J Neuropathol Exp Neurol; 2009 May; 68(5):456-73. PubMed ID: 19525894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrastriatal administration of human immunodeficiency virus-1 glycoprotein 120 reduces glial cell-line derived neurotrophic factor levels and causes apoptosis in the substantia nigra.
    Nosheny RL; Bachis A; Aden SA; De Bernardi MA; Mocchetti I
    J Neurobiol; 2006 Oct; 66(12):1311-21. PubMed ID: 16967504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine.
    Turchan J; Anderson C; Hauser KF; Sun Q; Zhang J; Liu Y; Wise PM; Kruman I; Maragos W; Mattson MP; Booze R; Nath A
    BMC Neurosci; 2001; 2():3. PubMed ID: 11252157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human Immunodeficiency Virus Type 1 gp120 and Tat Induce Mitochondrial Fragmentation and Incomplete Mitophagy in Human Neurons.
    Teodorof-Diedrich C; Spector SA
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30158296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EGCG mitigates neurotoxicity mediated by HIV-1 proteins gp120 and Tat in the presence of IFN-gamma: role of JAK/STAT1 signaling and implications for HIV-associated dementia.
    Giunta B; Obregon D; Hou H; Zeng J; Sun N; Nikolic V; Ehrhart J; Shytle D; Fernandez F; Tan J
    Brain Res; 2006 Dec; 1123(1):216-225. PubMed ID: 17078933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.